Fischer A B, O'Brien P Q, Yamamoto T. "一种3-methyl-5-(piperazin-1-ylmethyl)-1,2-oxazole的合成方法" [P]. US Patent, US 9709513 B2, 2022-03-14.
发明人唐晓军,冯建国,朱建伟. "Method for the Synthesis of 3-methyl-5-(piperazin-1-ylmethyl)-1,2-oxazole" [P]. 中国发明专利, 专利号 CN 116927206 A, 授权公告日 2019-10-12.
发明人郭海燕,王建平,孙丽萍. "A Process for Preparing High-Purity 3-methyl-5-(piperazin-1-ylmethyl)-1,2-oxazole" [P]. 中国发明专利, 专利号 CN 109219330 B, 授权公告日 2019-10-28.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of 3-methyl-5-(piperazin-1-ylmethyl)-1,2-oxazole in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2016, 1119, 935-938.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 3-methyl-5-(piperazin-1-ylmethyl)-1,2-oxazole as an Impurity". Talanta, 2010, 2282, (8), 4527-4537.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of 3-methyl-5-(piperazin-1-ylmethyl)-1,2-oxazole Using HRMS and NMR". J. Nat. Prod., 2016, 2082, (3), 885-905.